探究肌筋膜疼痛触发点灭活技术在原发性痛经治疗中的应用

目的:对肌筋膜疼痛触发点灭活技术在原发性痛经治疗中的应用效果实施分析和探究。方法:本研究选取2021年8月至2022年4月间本院收治的80例原发性痛经患者,将所有研究中患者随机分为对照组(n=40)和观察组(n=40)。对照组当中的所有患者实施常规治疗方式,观察组当中的患者使用肌筋膜疼痛触发点灭活技术,对两个组别之中患者治疗前后的视觉模拟评分情况、总频率评分以及治疗的总有效率进行对比。结果:治疗之前,两个组别之中患者的视觉模拟评分对比之后没有意义(P>0.05);治疗之后,两个组别之中患者的视觉模拟评分均得到降低,且观察组中患者的视觉模拟评分明显比对照组中患者更低,两组患者的数据比较差异显著(P<0.05)。治疗前,两个组别中患者的总频率评分比较没有统计学上意义(P>0.05);治疗后,对照组的总频率评分高于观察组,两组患者的数据实施比较后差异显著(P<0.05)。观察组内患者的临床总有效率为97.50%,对照组内患者的临床总有效率为77.05%,观察组内患者的临床总有效率明显高于对照组内患者,两组患者的数据实施比较后差异显著(P<0.05)。结论:在治疗因为肌筋膜疼痛触发点所导致的原发性痛经患者的过程当中,对患者实施肌筋膜疼痛触发点灭活技术能够达到较好的治疗效果,可以显著降低患者的疼痛程度,值得进行推广。

Objective:To analyze and explore the application of myofascial pain trigger point inactivation technology in the treatment of primary dysmenorrhea.Methods 80 patients with primary dysmenorrhea admitted to our hospital from August 2021 to April 2022 were randomly divided into control group(n=40)and observation group(n=40).All patients in the control group received conventional treatment,and patients in the observation group used myofascial pain trigger point inactivation technology to compare the visual simulation score,total frequency score and total effective rate of the two groups before and after treatment.Results Before treatment,there was no significant difference in visual simulation scores between the two groups(P>0.05);After treatment,the visual simulation scores of patients in the two groups were reduced,and the visual simulation scores of patients in the observation group were significantly lower than those in the control group.The data of patients in the two groups were significantly different(P<0.05).Before treatment,the total frequency scores of patients in the two groups were not statistically significant(P>0.05);After treatment,the total frequency score of the control group was higher than that of the observation group,and the difference between the two groups was significant(P<0.05).The total clinical effective rate of the patients in the observation group was 97.50%,and the total clinical effective rate of the patients in the control group was 77.05%.The total clinical effective rate of the patients in the observation group was significantly higher than that of the patients in the control group.There was a significant difference between the two groups after the implementation of the data(P<0.05).Conclusion In the process of treating patients with primary dysmenorrhea caused by myofascial pain trigger points,the application of myofascial pain trigger point inactivation technology to patients can achieve better therapeutic effect,can significantly reduce the pain level of patients,and is worthy of promotion.